Effects and Mechanism of AP39 on Ovarian Functions in Rats Exposed to Cisplatin and Chronic Immobilization Stress
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Premature ovarian failure (POF) rat models are essential for elucidating the hormonal and ovarian molecular mechanisms of human POF diseases and developing new therapeutic agents. This study aimed to compare the applicability of chronic immobilization stress (CIS) as a POF model with that of cisplatin and to examine the impact of AP39, a mitochondrial protective agent, on ovarian function in rats treated with cisplatin and CIS. Methods: Sixty Sprague–Dawley female rats were divided equally into six groups (10 per group): Control, Cisplatin, AP39, Cisplatin + AP39, CIS, and CIS + AP39. Ovarian dysfunction was induced with cisplatin (3 mg/kg) or CIS. Forced swim test, hormone concentrations, estrous cyclicity, histopathology, follicle counts, and molecular alterations in the ovary and mitochondria were analyzed. Results: In the CIS and cisplatin groups, mitochondrial biogenesis, egg quality, hormonal profile, estrous cycle, and folliculogenesis significantly declined. Nonetheless, most of the parameters with undesirable results did not normalize after AP39 administration. Conclusions: The cisplatin- and CIS-treated rats exhibited unshared deteriorated hormonal pathways and similarly disrupted gene expression patterns. Our current CIS model did not meet the human POF criteria, which include decreased estradiol levels, despite having advantages in terms of ease of modeling and reproducibility and demonstrating pathological changes similar to those observed in human POF. Therefore, rather than using this model as an POF model, using it as a representation of stress-induced ovarian dysfunction would be more appropriate.
Abstract
Objectives: Premature ovarian failure (POF) rat models are essential for elucidating the hormonal and ovarian molecular mechanisms of human POF diseases and developing new therapeutic agents. This study aimed to compare the applicability of chronic immobilization stress (CIS) as a POF model with that of cisplatin and to examine the impact of AP39, a mitochondrial protective agent, on ovarian function in rats treated with cisplatin and CIS. Methods: Sixty Sprague–Dawley female rats were divided equally into six groups (10 per group): Control, Cisplatin, AP39, Cisplatin + AP39, CIS, and CIS + AP39. Ovarian dysfunction was induced with cisplatin (3 mg/kg) or CIS. Forced swim test, hormone concentrations, estrous cyclicity, histopathology, follicle counts, and molecular alterations in the ovary and mitochondria were analyzed. Results: In the CIS and cisplatin groups, mitochondrial biogenesis, egg quality, hormonal profile, estrous cycle, and folliculogenesis significantly declined. Nonetheless, most of the parameters with undesirable results did not normalize after AP39 administration. Conclusions: The cisplatin- and CIS-treated rats exhibited unshared deteriorated hormonal pathways and similarly disrupted gene expression patterns. Our current CIS model did not meet the human POF criteria, which include decreased estradiol levels, despite having advantages in terms of ease of modeling and reproducibility and demonstrating pathological changes similar to those observed in human POF. Therefore, rather than using this model as an POF model, using it as a representation of stress-induced ovarian dysfunction would be more appropriate.
참고문헌 (43)
- Lebovic DI, "Premature ovarian failure : think ‘autoimmune disorder’", Sex Reprod Menopause, 2, pp.230~233 (2004)
- Podfigurna-Stopa A, "Premature ovarian insufficiency : the context of long-term effects", J Endocrinol Invest, 39, pp.983~990 (2016)
- Chen W, "Low expression of Mfn2is associated with mitochondrial damage and apoptosis of ovarian tissues in the premature ovarian failure model", PLoS One, 10, pp.e0136421~ (2015)
- Jeelani R, "Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality", Free Radic Biol Med, 110, pp.11~18 (2017)
- Delkhosh A, "Upregulation of FSHR and PCNA by administration of coenzyme Q10 on cyclophosphamide-induced premature ovarian failure in a mouse model", J Biochem Mol Toxicol, 33, pp.e22398~ (2019)
- Jang H, "Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the P27Kip1 promoter in primordial follicles", J Pineal Res, 63, pp.e12432~ (2017)
- Zhang T, "The comparison of animal models for premature ovarian failure established by several different source of inducers", Regul Toxicol Pharmacol, 81, pp.223~232 (2016)
- Zhao FL, "AP39, a mitochondria-targeted hydrogen sulfide donor, supports cellular bioenergetics and protects against Alzheimer’s disease by preserving mitochondrial function in APP", PS1 mice and neurons, 2016, pp.2016, 8360738~
- Yang T, "AP39 inhibits ferroptosis by inhibiting mitochondrial autophagy through the PINK1", parkin pathway to improve myocardial fibrosis with myocardial infarction, 2023, pp.165, 115195~
- Pomierny B, "The slow-releasing and mitochondria-targeted hydrogen sulfide(H2S)delivery molecule AP39 induces brain tolerance to ischemia", Int J Mol Sci, 22, pp.7816~ (2021)
- Magierowska K, "Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury", J Control Release, 348, pp.321~334 (2022)
- Libiad M, "Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers metabolic reprogramming in colon cells", J Biol Chem, 294, pp.12077~12090 (2019)
- Ahmad A, "AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo", Shock, 45, pp.88~97 (2016)
- Karwi QG, "AP39, a mitochondria-targeting hydrogen sulfide(H2S)donor, protects against myocardial reperfusion injury independently of salvage kinase signalling", Br J Pharmacol, 174, pp.287~301 (2017)
- Liu M, "Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K", AKT signaling pathway, 2018, pp.65, 769~781
- Li Y, "Exogenous hydrogen sulfide ameliorates diabetic myocardial fibrosis by inhibiting cell aging through SIRT6", AMPK autophagy, 2020, pp.11, 1150~
- Fu XY, "Effects of chronic unpredictable mild stress on ovarian reserve in female rats : feasibility analysis of a rat model of premature ovarian failure", Mol Med Rep, 18, pp.532~540 (2018)
- Şahin Z, "An evaluation of the effects of two chronic immobilization stress protocols on depression", anxiety-related behavior in male rats, 2019, pp.3, 535~541
- Xu M, "Chronic restraint stress induces excessive activation of primordial follicles in mice ovaries", PLoS One, 13, pp.e0194894~ (2018)
- Mao Y, "Validity of chronic restraint stress for modeling anhedonic-like behavior in rodents : a systematic review and meta-analysis", J Int Med Res, 50, pp.3000605221075816~ (2022)
- Keremu A, "Research on the establishment of chronic stress-induced premature ovarian failure the rat model and effects of Chinese medicine Muniziqi treatment", Mol Reprod Dev, 86, pp.175~186 (2019)
- Li D, "Differentially expressed genes in cisplatin-induced premature ovarian failure in rats", Anim Reprod Sci, 137, pp.205~213 (2013)
- Ferlazzo A, "The contribution of total and free iodothyronines to welfare maintenance and management stress coping in Ruminants and Equines : physiological ranges and reference values", Res Vet Sci, 118, pp.134~143 (2018)
- Beck-Peccoz P, "Premature ovarian failure", Orphanet J Rare Dis, 1, pp.9~ (2006)
- Şahin Z, "Comparison of the effects of immobilization stress and chronic mild stress models on depression-related behaviors in female rats : an assessment of a 10-day stress period", Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, 33, pp.153~157 (2019)
- Everds NE, "Interpreting stress responses during routine toxicity studies : a review of the biology, impact, and assessment", Toxicol Pathol, 41, pp.560~614 (2013)
- Liang B, "Restraint stress impairs oocyte developmental potential in mice : role of CRH-induced apoptosis of ovarian cells", Biol Reprod, 89, pp.64~ (2013)
- Fotsing D, "Effects of Gladiolus dalenii on the stress-induced behavioral, neurochemical, and reproductive changes in rats", Front Pharmacol, 8, pp.685~ (2017)
- Abdel-Fattah MD, "Effects of immobilization stress on some reproductive functions in adult female albino rats", Med J Cairo Univ, 86, pp.2457~2462 (2018)
- Sahin Z, "Gonadotropin levels reduced in seven days immobilization stress-induced depressive-like behavior in female rats", J Basic Clin Physiol Pharmacol, 33, pp.199~206 (2021)
- Lovick TA, "Estrous cycle and stress : influence of progesterone on the female brain", Braz J Med Biol Res, 45, pp.314~320 (2012)
- Zhou D, "Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury", Kidney Int, 84, pp.509~520 (2013)
- Abdelkader NF, "Neuroprotective effect of nebivolol against cisplatin-associated depressive-like behavior in rats", J Neurochem, 141, pp.449~460 (2017)
- Bernardi F, "High levels of serum allopregnanolone in women with premature ovarian failure", Gynecol Endocrinol, 12, pp.339~345 (1998)
- Yuemaier M, "Research on establishment of abnormal phlegmatic syndrome with premature ovarian failure rat model and Effects of Balgham Munziq treatment", Evid Based Complement Alternat Med, 2018, pp.3858209~ (2018)
- Divyashree S, "Long-term chronic stress exposure induces PCO phenotype in rat", Reproduction, 152, pp.765~774 (2016)
- Ibrahim MA, "Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis", Chem Biol Interact, 338, pp.109402~ (2021)
- Yu Y, "AP39 ameliorates high fat dietinduced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment", Exp Anim, 70, pp.553~562 (2021)
- Jiang J, "Hydrogen sulfide--mechanisms of toxicity and development of an antidote", Sci Rep, 6, pp.20831~ (2016)
- Falender AE, "TAF4b, a TBP associated factor, is required for oocyte development and function", Dev Biol, 288, pp.405~419 (2005)
- Venkatesh S, "Oxidative stress and ATPase6 mutation is associated with primary ovarian insufficiency", Arch Gynecol Obstet, 282, pp.313~318 (2010)
- Fontecha-Barriuso M, "The role of PGC-1α and mitochondrial biogenesis in kidney diseases", Biomolecules, 10, pp.347~ (2020)
- Filadi R, "Mitofusin 2 : from functions to disease", Cell Death Dis, 9, pp.330~ (2018)